You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

breast cancer survival

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Breast Cancer, Lobular Breast Carcinoma Trial in San Francisco (Blood Specimen)

Not yet recruiting
  • Metastatic Breast Cancer
  • Lobular Breast Carcinoma
  • Blood Specimen
  • San Francisco, California
    University of California, San Francisco
Jul 19, 2023

Breast Cancer, Telerehabilitation, Exercise Trial in Gaziantep (Aerobic exercise)

Recruiting
  • Breast Cancer
  • +3 more
  • Aerobic exercise
  • Gaziantep, Turkey
    Ramazan Cihad Yılmaz
Jan 31, 2023

Survival Rate of HER2-Low Breast Cancer Patients

Completed
  • HER2 Low Breast Carcinoma
  • immunohistochemistry (IHC) and in situ hybridization (ISH) Test
  • (no location specified)
Mar 2, 2023

Compare Overall Survival in Medicare Metastatic Breast Cancer

Active, not recruiting
  • Breast Cancer
  • New York, New York
    Pfizer New York
Oct 11, 2023

Survival of BCS vs Mx in Asymptomatic Screen-detected NPBC

Completed
  • Breast Cancer
  • Breast Conserving Surgery
  • Mastectomy
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Oct 22, 2023

Melanoma, Breast Cancer, Oncology Trial in Saint-Petersburg

Active, not recruiting
  • Melanoma
  • +7 more
    • Saint-Petersburg, Russian Federation
      N. N. Petrov Research Institute of oncology
    Sep 12, 2023

    Digital Breast Tomosynthesis in Breast Cancer Long-term

    Completed
    • Breast Cancer
    • DBT
    • DM
    • Kaohsiung, Taiwan
      Kaohsiung Veterans General Hospital
    Nov 1, 2022

    CDK4/6 Inhibitors in Hormone Receptor-positive Advanced Breast

    Not yet recruiting
    • Breast Cancer
    • CDK4/6 inhibitor
    • Shanghai, Shanghai, China
      Renji Hospital, School of Medicine, Shanghai Jiao Tong Universit
    Apr 5, 2023

    Pre-operative Therapy in Breast Cancer

    Not yet recruiting
    • Breast Cancer
    • pre-operative therapy
    • Shanghai, China
      Renji Hospital, School of Medicine, Shanghai Jiaotong University
    Nov 17, 2022

    Breast Cancer Stage IV Trial in Mansoura (comparing both arms as regard the objective response rate, toxicity profile, quality

    Recruiting
    • Breast Cancer Stage IV
    • comparing both arms as regard the objective response rate, toxicity profile, quality of life, progression free survival
    • Mansoura, Dakahlia, Egypt
      Oncology center mansoura university
    Jan 1, 2023

    Overall Survival in Japanese HR+/HER2- Advanced Breast Cancer

    Active, not recruiting
    • Breast Cancer
    • palbociclib plus letrozole
    • Chiba-shi, Chiba, Japan
    • +12 more
    Dec 15, 2022

    Breast Tumors Trial in Saint Louis (Doxorubicin, Trastuzumab, Cyclophosphamide)

    Terminated
    Has Results
    • Breast Neoplasms
    • Saint Louis, Missouri
      Washington University School of Medicine
    Oct 31, 2022

    Breast Tumors, Treatment, Metastatic Breast Cancer Trial (surgical treatment 1, surgical treatment 2, Systemic therapy)

    Not yet recruiting
    • Breast Neoplasms
    • +3 more
    • surgical treatment 1
    • +2 more
    • (no location specified)
    Jul 17, 2022

    Homologous Recombination-related Genesmutationsand HRD in Breast

    Not yet recruiting
    • Breast Cancer
    • HER2-low Breast Cancer
    • Standard Management
    • Guangzhou, Guangdong, China
      Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
    Jul 18, 2022

    Subjects Treated for Metastatic Breast Cancer: Contribution of

    Active, not recruiting
    • Cancer
    • Endocrine therapies
    • Bordeaux, France
      Insitut Bergonié
    Feb 2, 2022

    PREDICT Version 2.2 of Indian Women With Operable Breast Cancer

    Active, not recruiting
    • Operable Breast Neoplasms
    • prediction of overall survival using Web based PREDICTV2.0 portal
    • Mumbai, Maharashtra, India
      Tata Memorial Hospital
    Apr 28, 2022

    Trends of Young Breast Cancer in China

    Not yet recruiting
    • Breast Cancer
    • Clinical characteristics, diagnosis and treatment, survival status
    • (no location specified)
    Oct 12, 2021

    Breast Tumors Trial in Benxi, Shengyang, Shenyang (Expanded Mckissock surgery, Modified radical mastectomy)

    Recruiting
    • Breast Neoplasms
    • Expanded Mckissock surgery
    • Modified radical mastectomy
    • Benxi, Liaoning, China
    • +2 more
    Feb 6, 2022

    Invasive Breast Carcinoma, Stage I Breast Cancer AJCC v7, Stage IA Breast Cancer AJCC v7 Trial in United States (drug, other,

    Recruiting
    • Invasive Breast Carcinoma
    • +11 more
    • Conroe, Texas
    • +4 more
    May 3, 2022

    Breast Cancer Trial in Sweden (Omission of axillary clearance)

    Recruiting
    • Breast Cancer
    • Omission of axillary clearance
    • Gothenburg, Sweden
    • +21 more
    Apr 4, 2022

    Breast Cancer Trial in Denmark, Greece, Sweden (Omission of axillary clearance)

    Active, not recruiting
    • Breast Cancer
    • Omission of axillary clearance
    • Aabenraa, Denmark
    • +32 more
    Apr 4, 2022

    Patients With Invasive Breast Cancer

    Recruiting
    • Breast Cancer-specific Survival
    • neoadjuvant/adjuvant therapy
    • Novosibirsk, Russian Federation
      Evgeny Pokushalov
    Mar 11, 2021

    Metastatic Breast Cancer Starting a Third Line Chemo Trial in France (Construction of a prognostic score (non-drug intervention

    Active, not recruiting
    • Metastatic Breast Cancer Starting a Third Line Chemotherapy
    • Construction of a prognostic score (non-drug intervention types)
    • Albi, France
    • +15 more
    Oct 15, 2021

    Breast Cancer Trial in Milano (Community-based participatory research on diet and lifestyle)

    Recruiting
    • Breast Cancer
    • Community-based participatory research on diet and lifestyle
    • Milano, MI, Italy
      Fondazione Irccs Istituto Nazionale Dei Tumori
    Sep 15, 2021

    ER Positive / HER-2 Negative Advanced Breast Cancer

    Recruiting
    • Breast Cancer
    • Establishment of a Survival Prediction Model
    • Guangzhou, Guangdong, China
    • +1 more
    Dec 19, 2020